Yes, that's the one...
Methods
• ClinicalTrials.gov identifier: NCT02310022.
• This was an open-label, randomized, crossover trial. A sample of 42 men and women received 4 g/d MAT9001 and EPA-EE in random order, for 14-day treatment periods, separated by ≥35 days of wash-out (refer to Figure 1 for study design).
• Subjects were housed in a clinical research unit (Pharma Medica Research Inc., Mississauga, Ontario, Canada) for the duration of each treatment period.
• The dose (four 1 g capsules) was given daily, 30 minutes after consumption of a breakfast meal. On day 13 of each treatment, subjects consumed a low-fatbreakfast (502 kcal; 4/82/14% kcal from fat, carbohydrate and protein, respectively) and samples were collected over a 24-hour period for pharmacokinetic analyses.
It appears that the people were trapped together in some sort of containment facility, where they were probably also subjected to some form of torture, forced to renounce their religions, and compelled to root for the New England Patriots.
News 
Market Data 
Discover 
